Individuals with a personal or family history of medullary thyroid carcinoma (MTC) Those diagnosed with Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Pregnant or breastfeeding individuals Patients with gastric emptying disorders (e.g., gastroparesis) Anyone with a known allergy to GLP-1 medications Individuals currently experiencing pancreatitis or at high risk for it Anyone whose medical history or medications contraindicate GLP-1 therapy (evaluated during consultation) Possible Side Effects Nausea, especially during initial dose increases Vomiting or mild gastrointestinal discomfort Constipation or diarrhea Decreased appetite Fatigue or low energy Bloating or gas Injection-site irritation Rare but serious risks such as pancreatitis or gallbladder issues Why Choose Juventas Wellness for GLP 1 Therapy in Denver
When paired with our weight loss consultations, nutritional counseling, and lab services (like CBC, CMP, Thyroid panels, and Hemoglobin A1C), lipotropic injections become a cornerstone of a fully customized weight loss plan
If oesophagitis (Los Angeles classification B, C, or D) is seen during screening, the patient should receive 812 weeks of proton pump inhibitor (PPI) therapy for the healing of oesophagitis, followed by a repeat endoscopy
Taking Reglan (metoclopramide) as a treatment for gastroparesis
